Evidence map›Paper›PMID 34065341›Full record

ArticleCancers2021

Long-Term Survival Effect of the Interval between Postoperative Chemotherapy and Radiotherapy in Patients with Completely Resected Pathological N2 Non-Small-Cell Lung Cancer.

Shih-Min Lin, Hsiu-Ying Ku, Che-Yu Hsu, Chih-Liang Wang, Gee-Chen Chang, Cheng-Shyong Chang, Tsang-Wu Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 1 country.

Shih-Min LinDepartment of Radiation Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan.
Hsiu-Ying KuNational Institute of Cancer Research, National Health Research Institute, Miaoli 350, Taiwan.
Che-Yu HsuDivision of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei 100, Taiwan.
Chih-Liang WangDepartment of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan.
Gee-Chen ChangSchool of Medicine and Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.ORCID 0000-0002-1802-417X
Cheng-Shyong ChangDivision of Hematology and Oncology, Chang Bing Show Chwan Memorial Hospital, Changhua 505, Taiwan.
Tsang-Wu LiuNational Institute of Cancer Research, National Health Research Institute, Miaoli 350, Taiwan.
Asia University · TWChang Bing Show Chwan Memorial Hospital · TWChang Gung Memorial Hospital · TWChang Gung University · TWChung Shan Medical University Hospital · TWNational Health Research Institutes · TWNational Taiwan University · TW

Funding

Health Promotion Administration, Ministry of Health and Welfare A1081116Ministry of Science and Technology, Taiwan MOST 107-2634-F-002-016Ministry of Science and Technology, Taiwan MOST 108-2634-F-002-013-Ministry of Science and Technology, Taiwan MOST 109-2314-B-002-105-MY2Ministry of Science and Technology, Taiwan MOST 109-2634-F-002-028
6 · The paper itself

Abstract

(1) Purpose: To investigate the effects of the time interval between initiation of adjuvant chemotherapy and radiotherapy on survival outcomes in patients with completely resected stage IIIA pN2 non-small-cell lung cancer (NSCLC); (2) Methods: Data on 2515 patients with completely resected stage IIIA pN2 NSCLC in 2007-2017 were extracted from the Taiwan Cancer Registry Database. The survival outcomes in patients who underwent concurrent chemoradiotherapy (CCRT) and sequential chemotherapy and radiotherapy (SCRT) with either a short (SCRT1) or long (SCRT2) interval between treatments were estimated using Kaplan-Meier, Cox regression, and propensity score matching (PSM); (3) Results: Multivariate analyses of OS showed that SCRT2 (hazard ratio [HR] 0.64,

Indexed as

IMRTNSCLCpN2postoperative chemotherapypostoperative radiotherapy

Identifiers

PMID34065341
PMCPMC8160867
OpenAlexW3163820652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.